EUVIMEDEUVIMED entdecken
Open Access

Computationally informed point of departure evaluation for proarrhythmic cardiotoxicity assessment using 3D engineered cardiac microtissues from human iPSC-derived cardiomyocytes

Mark C Daley iD, Peter Bronk, Tae Yun Kim, Arvin H Soepriatna, Cao T Tran, Ulrike Mende, Kareen L K Coulombe, Bum-Rak Choi

Toxicological Sciences · 2025

DOI: 10.1093/toxsci/kfaf094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Mark C Daley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biomedical Engineering, Brown University, Providence, RI 02912, United States. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells, Arrhythmias, Cardiac. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institution of General Medical Sciences, Brown University Biomedical Innovation to Impact, COBRE Pilot.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a promising new approach for in vitro proarrhythmic cardiotoxicity assessment. However, variation due to differentiation batch, individual sample variation, and non-linear responses to test drugs complicate the prediction of proarrhythmic drug concentrations. This study combines a computational human action potential (AP) model of hERG channel block with experimental data from three-dimensional hiPSC-CM engineered microtissues to optimize point of departure (POD) estimation of drug-induced prolongation of AP duration (APD). Computer simulations predicted that APD prolongation from hERG block follows a logistic curve and that >81% hERG block induced early afterdepolarizations (EADs), which significantly shifted the APD response curve. Curve fitting of APD response by logistic, bilinear breakpoint, and maximal curvature was more accurate prior to EAD onset. Goodness-of-fit testing indicated that logistic regression with ≥6 test concentrations was sufficient to accurately estimate PODs. Power analysis, based on experimental variations between batches (n = 14), molds (n = 57), and microtissues (n = 1701), predicted that PODs from 2 ∼ 3 batches with 10 microtissues per mold using a 5% threshold for APD prolongation detected proarrhythmic cardiotoxicity with a negligible false positive rate. We then applied this POD analysis to hiPSC-CM microtissue data after treatment with well-characterized drugs (i.e. cisapride, ranolazine, quinidine, and verapamil). Using bootstrapping, we estimated PODs and confidence intervals that matched concentrations known to cause proarrhythmic effects in patients. This study identified a robust method for calculating PODs for proarrhythmic cardiotoxicity risk in vitro and developed a framework for experimental design in this and other in vitro platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacInduced Pluripotent Stem CellsArrhythmias, CardiacHumansAction PotentialsCardiotoxicityComputer SimulationCell DifferentiationModels, CardiovascularERG1 Potassium ChannelTissue Engineering

Stichwörter der Autor:innen

benchmark dose analysiscardiac arrhythmiascardiotoxicityhiPSC-derived cardiac microtissuesrisk assessment

Substanzen

ERG1 Potassium Channel

Autor:innen und Institutionen

  • Center for Biomedical Engineering, Brown University, Providence, RI 02912, United States.
  • Cardiovascular Research Center, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI 02903, United States.
  • Department of Physics, Korea University, Seoul, 02841, Korea.
  • Cardiovascular Institute, Rhode Island Hospital, Providence, RI 02903, United States.

ORCID-Profile: Mark C Daley

Förderung

  • National Institution of General Medical Sciences
  • Brown University Biomedical Innovation to Impact
  • COBRE Pilot
  • National Institution of Health
  • NIEHS NIH HHS
  • NIGMS NIH HHS
  • National Institute of Environmental Health Sciences

Zitieren

APA

Daley, M. C., Bronk, P., Kim, T. Y., Soepriatna, A. H., Tran, C. T., Mende, U., Coulombe, K. L. K., & Choi, B. R. (2025). Computationally informed point of departure evaluation for proarrhythmic cardiotoxicity assessment using 3D engineered cardiac microtissues from human iPSC-derived cardiomyocytes. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf094

Vancouver

Daley MC, Bronk P, Kim TY, Soepriatna AH, Tran CT, Mende U, et al. Computationally informed point of departure evaluation for proarrhythmic cardiotoxicity assessment using 3D engineered cardiac microtissues from human iPSC-derived cardiomyocytes. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf094

BibTeX
@article{Daley2025,
  author = {Daley, Mark C and Bronk, Peter and Kim, Tae Yun and Soepriatna, Arvin H and Tran, Cao T and Mende, Ulrike and Coulombe, Kareen L K and Choi, Bum-Rak},
  title = {Computationally informed point of departure evaluation for proarrhythmic cardiotoxicity assessment using 3D engineered cardiac microtissues from human iPSC-derived cardiomyocytes},
  journal = {Toxicological Sciences},
  year = {2025},
  doi = {10.1093/toxsci/kfaf094}
}
Kostenlos starten →